Regeneron's Lumina-1 Trial

Regeneron's LUMINA-1 Trial

Int'l Fibrodysplasia Ossificans Progressiva Assoc

Regeneron's LUMINA-1 Trial hosted by FOP Friends

Int'l Fibrodysplasia Ossificans Progressiva Assoc

Regeneron’s Mission

Neuroimmunology of the Skin Regulation of the Nervous System by the Immune System

Society for Investigative Dermatology

Regeneron's science chief on starting clinical trials for Covid-19 antibody drug

CNBC Television

Beyond 100,000 Exomes: Insights & Lessons from Regeneron's Large Scale Sequencing in the Cloud

Why Regeneron's antibody drug will be in short supply

CNBC Television

Regeneron’s Mission: Our Heartbeat

Regeneron trial in WNY

UW Health testing same Regeneron Pharmaceutical clinical trial

Channel 3000 / News 3 Now

First Regeneron trial began at Holy Name Medical Center

NJ Spotlight News

Regeneron’s Mission: Our Snapshot

Phase I/II trial of EP0031, a next generation selective RET inhibitor

Antibody Drug Regeneron Enters Clinical Trials At UM

Regeneron says antibody cocktail prevented COVID-19 infections in trials

Regeneron aims for COVID-19 drug trials by early summer

CNBC Television

Dr. Nachman weighs in on the new Regeneron study

Regeneron stock surges on positive results in eye disease drug trial